Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
20 participants
INTERVENTIONAL
2018-02-01
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ketamine vs Propofol for Sedation During Pediatric Bronchoscopy
NCT02743104
Safety and Efficacy of Sufentanil Combined With Midazolam in Bronchoscopy Under Conscious Sedation: Retrospective Study
NCT03890094
Study Comparing the Use of Remifentanil Versus Propofol for Performing Bronchial Fibroscopy
NCT01872754
Effect of Propofol Versus Remimazolam Intravenous Anesthesia on Respiratory Depression
NCT06816173
Sedation Compaired With Anesthesia With THRIVE in Endotracheal Intubation With Difficult Airways
NCT04924621
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group DR
Patients sedated with dexmedetomidine and remifentanil.
Dexmedetomidine
Dexmedetomidine was used as a sedation agent with less side effect on respiratory system.
Remifentanil
Remifentanil was used to prevent cough induced by bronchoscopy.
Group LMA
General anesthesia was applied using laryngeal mask.
Laryngeal mask
Laryngeal mask was used to ensure respiration function during general anesthesia.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
Dexmedetomidine was used as a sedation agent with less side effect on respiratory system.
Remifentanil
Remifentanil was used to prevent cough induced by bronchoscopy.
Laryngeal mask
Laryngeal mask was used to ensure respiration function during general anesthesia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patients aged 18 to 65 years
* American Society of Anesthesiologists (ASA) Physical Status Classification I-II
* BMI 18.5-25kg/m2
* Subjects provide informed consent
Exclusion Criteria
* Coagulation disorder
* Repeat bronchoscopy (more than 3 times)
* Severe liver and renal dysfunction
* Cardiovascular and cerebrovascular diseases
* Pregnancy
* Chronic opioid user
* Drug abusers or addicts
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Ruijin Hospital
OTHER
Shanghai Pulmonary Hospital, Shanghai, China
OTHER
Changhai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jia-feng Wang
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Anesthesiology, Changhai Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SED-TFB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.